Vimarsana
Biggest News Aggregation in the World

Page 8 - Grant Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grant Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grant Date Today - Breaking & Trending Today

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, granted equity awards on November 30, 2023 that were previously approved by the Compensation Committee of its...

Allego N : Index to the Interim Condensed Consolidated Financial Statements - Form 6-K -November 28, 2023 at 07:29 am EST - Vimarsana News

Allego N : Index to the Interim Condensed Consolidated Financial Statements - Form 6-K -November 28, 2023 at 07:29 am EST

Index to the Interim Condensed Consolidated Financial Statements Interim condensed...

Hargreaves Lansdown : Performance Share Plan Rules -November 08, 2023 at 06:57 am EST - Vimarsana News

Hargreaves Lansdown : Performance Share Plan Rules -November 08, 2023 at 06:57 am EST

Rules of the Hargreaves Lansdown plc Performance Share Plan ...

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 03, 2023 -- ORIC Pharmaceuticals, Inc. , a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01.11.2023 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on October 31, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s ...